Oculoplastic Surgery Market Size, Share & Industry Analysis, By Procedure (Eyelid Surgery, Face Lift, Brow Lift, Forehead Lift, Pediatric Oculoplastic Surgery, Others), By End-Users (Hospitals , Ambulatory Surgical Centres, Ophthalmology Clinics, Eye Research Institutes) And Regional Forecast, 2024-2032

Oculoplastic surgery is a common term used for surgeries executed around the orbit, eyelid, and/or the face to improve the overall appearance of the patients. It is also called as ocular plastic surgery.  This surgery can be used to deal with many medical conditions that arise from aging, injuries, disfiguring congenital disabilities, and even conditions caused by the thyroid, specifically Graves’ disease. Many of the medical conditions like ptosis, brow ptosis, entropion, ectropion, eyelid growths, blockage of the tear duct, reconstructive surgery, blepharoplasty can be irritating and/or affect one’s vision making oculoplastic surgery medically necessary. These procedures are known to reduce the incidence of postoperative complications significantly, can treat eye-related disorders, such as visual impairment, crimps near the eyes, and sagy eyes, which are expected to drive the market growth.

Factors such as growing disposable income, increasing acceptance of various oculoplastic surgeries, quick recovery time, same-day procedure, and aspiration to look young are anticipated to boost the market for oculoplastic operation. Moreover, social media and celebrities have proven to be a strong influence on consumers in the medical aesthetics industry. For instance, according to multiple studies conducted in the U.K., approximately 55% of facial plastic surgeons said patients in their practice reported that they were motivated by a desire to look better in selfies in 2018, up from 19% in 2016. In addition to that, the growth of the market can be attributed to the increasing prevalence of diabetic retinopathy and the rising geriatric population.

However, the high costs of devices and the shortage of skilled professionals with expertise in ophthalmic surgery can restrain the growth of the market.

Key Market Driver -

Increasing prevalence of diabetic retinopathy, aspiration to look young and growing disposable income are projected to boost the market

Key Market Restraint -

The high costs of devices and the dearth of skilled professionals are likely to hinder the market growth.

Market Segmentation:

The global oculoplastic surgery market is expected to be segmented based on procedure, end-users, and region. Based on the procedure, the market can be segmented into eyelid surgery, facelift, brow lift, forehead lift, pediatric oculoplastic surgery, and others. Based on the end-users, the market can be segmented into hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes.

Geographically, the oculoplastic surgery market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Players Covered:

The major companies in the global oculoplastic surgery market report include Integra Life Sciences Corporation, Ophthalmic Instruments Inc., Bausch & Lomb Incorporated, Bolton Surgical Ltd., BLINK MEDICAL, B. Braun Melsungen AG, Zimmer Biomet, TEKNO-MEDICAL Optik-Chirurgie GmbH, Stanford Health Care, Sklar Surgical Instruments and other prominent players.

Key Insights:

• Key Industry Developments - Mergers, Acquisitions, and Partnerships


• Introduction of New Products / Approvals (By Major Players)


• Recent Eye Research & Development Activities

Regional Analysis:

Geographically, the global oculoplastic surgery market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Due to the growing volume of procedures and high treatment costs, North America is expected to lead the market. In the last four years alone, North America has a sizeable adaptable population with millions of aesthetic users, and the rate tripled in the U.S. in this period. The U.S. is expected to lead the regional oculoplastic surgery market, motivated by the high number of oculoplastic procedures in the U.S. According to the American Society of Aesthetic Plastic Surgeons 2018, blepharoplasty-removal of superfluous tissue around the eyelids is one of the most common cosmetic procedures in the U.S. In addition to that around 115,000 such procedures were performed in the U.S. alone. Europe is the second-largest growing region for the market globally. It is expected to grow significantly over the forecast period due to the various technological advancements. The Asia Pacific is likely to adopt this market due to the increasing awareness among developing and populous countries like India and China. And the Middle East and Africa are growing steadily in the market.

To gain extensive insights into the market, Request for Customization

Segmentation

Oculoplastic Surgery Market Industry Developments

• In December 2019 – Bausch & Lomb Incorporated, a leading global eye health company, announced the introduction of the enVista toric MX60ET hydrophobic acrylic intraocular lens (IOL) with StableFlex technology, which provides improved material properties to deliver enhanced optic recovery following delivery.


• In May 2019, Novartis announced today its agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra (lifitegrast ophthalmic solution) 5% worldwide. Xiidra is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.